O'Callaghan DS[au] - Search Results

Year	Number of Results
2006	1
2007	2
2008	3
2009	1
2010	7
2011	8
2012	8
2013	7
2015	3
2016	1
2017	1
2021	0

1

Current management approaches to portopulmonary hypertension.

Savale L, O'Callaghan DS, Magnier R, Le Pavec J, Hervé P, Jaïs X, Seferian A, Humbert M, Simonneau G, Sitbon O. Savale L, et al. Among authors: o callaghan ds. Int J Clin Pract Suppl. 2011 Jan;(169):11-8. doi: 10.1111/j.1742-1241.2010.02600.x. Int J Clin Pract Suppl. 2011. PMID: 21176011 Review.

2

Novel medical therapies for pulmonary arterial hypertension.

O'Connell C, O'Callaghan DS, Humbert M. O'Connell C, et al. Among authors: o callaghan ds. Clin Chest Med. 2013 Dec;34(4):867-80. doi: 10.1016/j.ccm.2013.08.002. Clin Chest Med. 2013. PMID: 24267310 Review.

3

Treatment of pulmonary arterial hypertension with targeted therapies.

O'Callaghan DS, Savale L, Montani D, Jaïs X, Sitbon O, Simonneau G, Humbert M. O'Callaghan DS, et al. Nat Rev Cardiol. 2011 Jul 19;8(9):526-38. doi: 10.1038/nrcardio.2011.104. Nat Rev Cardiol. 2011. PMID: 21769113 Review.

4

Differentiating pulmonary cavities.

O'Connell C, Abdul Aziz M, O'Keane JC, Healy D, O'Callaghan DS. O'Connell C, et al. Among authors: o callaghan ds. Eur Respir Rev. 2013 Jun 1;22(128):191-2. doi: 10.1183/09059180.00005012. Eur Respir Rev. 2013. PMID: 23728876 Free article. No abstract available.

5

An update on medical therapy for pulmonary arterial hypertension.

Wu Y, O'Callaghan DS, Humbert M. Wu Y, et al. Among authors: o callaghan ds. Curr Hypertens Rep. 2013 Dec;15(6):614-22. doi: 10.1007/s11906-013-0394-8. Curr Hypertens Rep. 2013. PMID: 24122306 Review.

6

A critical analysis of survival in pulmonary arterial hypertension.

O'Callaghan DS, Humbert M. O'Callaghan DS, et al. Eur Respir Rev. 2012 Sep 1;21(125):218-22. doi: 10.1183/09059180.00003512. Eur Respir Rev. 2012. PMID: 22941886 Free article. Review.

7

Portopulmonary hypertension: light at the end of the tunnel?

Sitbon O, O'Callaghan DS, Savale L. Sitbon O, et al. Among authors: o callaghan ds. Chest. 2012 Apr;141(4):840-842. doi: 10.1378/chest.11-2378. Chest. 2012. PMID: 22474144 No abstract available.

8

Pulmonary veno-occlusive disease: recent progress and current challenges.

Montani D, O'Callaghan DS, Savale L, Jaïs X, Yaïci A, Maitre S, Dorfmuller P, Sitbon O, Simonneau G, Humbert M. Montani D, et al. Among authors: o callaghan ds. Respir Med. 2010 Jul;104 Suppl 1:S23-32. doi: 10.1016/j.rmed.2010.03.014. Epub 2010 Apr 24. Respir Med. 2010. PMID: 20456932 Free article. Review.

9

Endothelin receptor antagonists for the treatment of pulmonary arterial hypertension.

O'Callaghan DS, Savale L, Yaïci A, Natali D, Jaïs X, Parent F, Montani D, Humbert M, Simonneau G, Sitbon O. O'Callaghan DS, et al. Expert Opin Pharmacother. 2011 Jul;12(10):1585-96. doi: 10.1517/14656566.2011.564159. Epub 2011 Apr 20. Expert Opin Pharmacother. 2011. PMID: 21504371 Review.

10

The role of inflammation in the pathogenesis of non-small cell lung cancer.

O'Callaghan DS, O'Donnell D, O'Connell F, O'Byrne KJ. O'Callaghan DS, et al. J Thorac Oncol. 2010 Dec;5(12):2024-36. doi: 10.1097/jto.0b013e3181f387e4. J Thorac Oncol. 2010. PMID: 21155185 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results